Valuation
52-Week Range
12.62 - 23.75
Annual income statement
#
SCHOTT Pharma AG & Co. KGaA annual revenue, operating income and net income in EUR, 2020 to 2025. Revenue was 986.2m in 2025.
| Year |
Revenue (EUR) |
Operating income |
Net income |
Net margin |
| 2025 |
986.2m |
187.0m |
146.5m |
14.9% |
| 2024 |
957.1m |
190.0m |
149.7m |
15.6% |
| 2023 |
898.6m |
170.9m |
151.8m |
16.9% |
| 2022 |
821.1m |
169.3m |
125.4m |
15.3% |
| 2021 |
648.7m |
115.2m |
100.8m |
15.5% |
| 2020 |
584.2m |
91.6m |
77.5m |
13.3% |
| Date |
Type |
Details |
Price |
Amount |
|